View more on these topics

Aviva cutting premiums for critical cover with exclusions

Aviva is reducing premiums for its critical-illness plan when policy exclusions apply.

Premiums on policies which have cancer or multiple sclerosis exclusions will be cut.

Aviva says this means customers with pre-existing conditions or family history can still get CI cover and pay only for the level of cover they receive.

Aviva chief underwriter Michael Whyte says: “Critical-illness cover offers financial support to customers during a particularly difficult time.

“This latest improvement represents another step in Aviva making our cover more accessible, affordable and relevant to our customers.”

Lifesearch senior policy adviser Matt Morris says other providers should follow Aviva’s example. He says: “They have no reason not to. It is good for consumers and good for the industry as it reduces the number of policies not taken up.

“This initiative should be included for major illness on both critical-illness and income protection products. Fortis and Aviva are the only insurers to offer it on both products at present. It is time for everyone else to move with the times.”

Highclere Financial Services partner Alan Lakey says: “This is another example of common sense and treating customers fairly. The truth is that those providers yet to incorporate premium reductions where cover is diminished are charging for a level of protection that is not being offered. I hope that all those providers sitting back and watching will follow suit.”



Leave group pensions out of the RDR

If all an adviser does all day is talk to businesses about setting up group pensions, why should he be required to train for giving individual advice? Yet this is another of the inapp-ropriate burdens that the FSA is placing on the group pension industry by including it within the remit of the retail distri-bution […]

Artemis set for buyout

Artemis Investment Management is set to be bought by its senior management and US fund house Affiliated Managers Group.


News and expert analysis straight to your inbox

Sign up


    Leave a comment